Evidence map›Paper›PMID 37686526›Full record

ArticleCancers2023

Histomorphometric Analysis of 38 Giant Cell Tumors of Bone after Recurrence as Compared to Changes Following Denosumab Treatment.

Sophia Arndt, Wolfgang Hartmann, András Rókusz, Benedikt Leinauer, Alexandra von Baer, Markus Schultheiss, Jessica Pablik, Hagen Fritzsche, Carolin Mogler, Imre Antal and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Sophia ArndtInstitute of Pathology, University Ulm, 89081 Ulm, Germany.
Wolfgang HartmannGerhard-Domagk-Institute of Pathology, University Hospital Münster, 48149 Münster, Germany.
András RókuszInstitute of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
Benedikt LeinauerInstitute of Pathology, University Ulm, 89081 Ulm, Germany.ORCID 0000-0002-2516-4787
Alexandra von BaerClinic for Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Ulm, 89081 Ulm, Germany.
Markus SchultheissClinic for Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Ulm, 89081 Ulm, Germany.
Jessica PablikInstitute of Pathology, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Hagen FritzscheCentre for Orthopedics, Trauma and Plastic Surgery, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Carolin MoglerInstitute of Pathology, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0003-3400-7254
Imre AntalInstitute of Orthopedics, Semmelweis University, 1085 Budapest, Hungary.
Daniel BaumhoerBone Tumor Reference Centre at the Institute of Pathology, University Hospital Basel and University of Basel, 4003 Basel, Switzerland.ORCID 0000-0002-2137-7507
Kevin MellertInstitute of Pathology, University Ulm, 89081 Ulm, Germany.
Peter MöllerInstitute of Pathology, University Ulm, 89081 Ulm, Germany.
Miklós SzendrőiInstitute of Orthopedics, Semmelweis University, 1085 Budapest, Hungary.
Gernot JundtBone Tumor Reference Centre at the Institute of Pathology, University Hospital Basel and University of Basel, 4003 Basel, Switzerland.
Thomas F E BarthInstitute of Pathology, University Ulm, 89081 Ulm, Germany.
Universität Ulm · DESemmelweis University · HUUniversity Hospital Carl Gustav Carus · DEUniversity Hospital Ulm · DEUniversity of Basel · CHTechnical University of Munich · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell tumor of bone (GCTB) is an osteolytic tumor driven by an

Indexed as

denosumabgiant cell tumorimmunohistochemical profilingmalignant transformationrecurrence

Identifiers

PMID37686526
PMCPMC10486357
OpenAlexW4386168721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.